DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
PluriSln 1 (HB3573)
Description:SCD1 inhibitor. Selectively eliminates undifferentiated hPSCs from culture.
Purity:>99%
-
Pexidartinib (PLX3397) (HB8991)
Description:Potent CSF-1R inhibitor. Widely used microglia-depletion agent.
Purity:>98%
-
PNU 74654 (HB0528)
Description:β-catenin inhibitor. Wnt pathway inhibitor. Promotes neural differentiation of hPSCs.
Purity:>99%
- Description:
Protease & Phosphatase Inhibitor Cocktail solution (EDTA free)
- Description:
Protease & Phosphatase Inhibitor Cocktail solution (plus EDTA)
- Description:
Protease Inhibitor Cocktail powder for general use to inhibit a broad range of proteases and esterases
- Description:
Protease Inhibitor Cocktail (EDTA free) solution for plant cell and tissue extract use
